Calvin Yeang

Has grant

Assistant Professor

University of California, San Diego

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Refining Cardiovascular Risk Attributed to Low-Density Lipoprotein Cholesterol

Open Date: 2020-07-01

Close Date: 2021-04-01

Grant: Close

Defining the Role of Lipoprotein(a) and its Oxidized Phospholipids in the Development and Progression of Calcific Aortic Valve Disease Using Unique Transgenic Mouse Models

Open Date: 2020-02-17

Close Date: 2025-01-31

Grant: Close

Understanding how Clonal Hematopoiesis Mediates Cardiovascular Risk Through Single Cell Transcriptome and Epigenome Analysis of Clonal Immune Cells

Open Date: 2018-08-01

Close Date: 2019-07-01

Grant: Close

The Role of Lipoprotein(a) and Oxidized Phospholipids in the Development and Treatment of Aortic Valve Stenosis

Open Date:

Close Date:

Articles (10)

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (2)

Peter Willeit

Associate Professor of Clinical Epidemiology

Medical University of Innsbruck

AUSTRIA

View details

Amos Baruch

Head of Biomarker Development

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Calvin Yeang

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

Lipoprotein(a) Testing Trends in a Large Academic Health System in the United States

Trends in testing and prevalence of elevated Lp(a) among patients with aortic valve stenosis

Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association.

Clonal hematopoiesis driven by DNMT3A and TET2 mutations: role in monocyte and macrophage biology and atherosclerotic cardiovascular disease.

PCSK9 Inhibition and Oxidized Phospholipids.

Novel method for quantification of lipoprotein(a)-cholesterol: implications for improving accuracy of LDL-C measurements.

The interconnection between lipoprotein(a), lipoprotein(a) cholesterol and true LDL-cholesterol in the diagnosis of familial hypercholesterolemia.

The interconnection between lipoprotein(a), lipoprotein(a) cholesterol and true LDL-cholesterol in the diagnosis of familial hypercholesterolemia

Low-Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events.

Low-Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events

Collaborators (2)

Peter Willeit

Amos Baruch

Make your next move.